Loading...
QuidelOrtho Corp (QDEL) is not a strong buy at the moment based on the user's long-term investment strategy and beginner knowledge level. The technical indicators are bearish, financial performance shows mixed results with revenue declining, and there are no significant positive catalysts or trading signals to suggest immediate upside potential. Holding or waiting for a clearer entry point is recommended.
The technical indicators are bearish. The MACD histogram is negative (-0.301) and contracting, RSI is neutral at 39.013, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 23.625, with key support at 21.26 and resistance at 25.989.

Insiders are buying, with a significant increase of 2578.44% in insider buying over the last month. This indicates confidence from company insiders.
No recent news or significant events to drive the stock higher. Analysts have mixed ratings, with no strong buy recommendations. The financial performance shows declining revenue and a negative EPS, despite improvements in net income.
In Q3 2025, revenue dropped by -3.74% YoY to $699.9 million. Net income improved significantly to -$733 million (up 3583.42% YoY), and EPS increased to -10.78 (up 3493.33% YoY). However, gross margin slightly declined to 41.13% (-0.44% YoY).
Analysts have mixed views. Citi and UBS raised their price targets to $30 but maintain Neutral ratings, while JPMorgan raised its target to $25 but keeps an Underweight rating. UBS highlights mixed 2026 guidance with free cash flow concerns.